Kirkland & Ellis represented the placing agents in the deal. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd (“Kelun-Biotech”) announced it completed the H-share placing (the “H-Share Placing”). Kelun-Biotech...
Kelun-Biotech Biopharmaceutical’s H-Share Placing
Bank of Guizhou Co. Ltd.’s HK$5.456 Billion Initial Public Offering
Clifford Chance and KWM advised Bank of Guizhou Co. Ltd. on its HK$5.456 billion initial public offering and listing on the Hong Kong Stock Exchange, while...